The global market for Placental Stem Cell Therapy for Neurological Disorders was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson"s disease, Alzheimer"s, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.

The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there"s a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.

This report aims to provide a comprehensive presentation of the global market for Placental Stem Cell Therapy for Neurological Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Stem Cell Therapy for Neurological Disorders.

The Placental Stem Cell Therapy for Neurological Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Placental Stem Cell Therapy for Neurological Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Placental Stem Cell Therapy for Neurological Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Placental Stem Cell Therapy for Neurological Disorders Market Report

Report Metric	Details
Report Name	Placental Stem Cell Therapy for Neurological Disorders Market
Segment by Type	Allogeneic Placental Stem Cell Therapy Autologous Placental Stem Cell Therapy
Segment by Application	Hospitals and Specialist Clinics Clinical Research Institute
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Mesoblast, Pleurite Therapeutic, Athersys, Cordlife India, Life Cell, Cryo-Cell, CBR Systems, ReNeuron Group, Cynata, Celularity, Americord Registry, ReeLabs
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Stem Cell Therapy for Neurological Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Placental Stem Cell Therapy for Neurological Disorders Market report?

Ans: The main players in the Placental Stem Cell Therapy for Neurological Disorders Market are Mesoblast, Pleurite Therapeutic, Athersys, Cordlife India, Life Cell, Cryo-Cell, CBR Systems, ReNeuron Group, Cynata, Celularity, Americord Registry, ReeLabs

What are the Application segmentation covered in the Placental Stem Cell Therapy for Neurological Disorders Market report?

Ans: The Applications covered in the Placental Stem Cell Therapy for Neurological Disorders Market report are Hospitals and Specialist Clinics, Clinical Research Institute

What are the Type segmentation covered in the Placental Stem Cell Therapy for Neurological Disorders Market report?

Ans: The Types covered in the Placental Stem Cell Therapy for Neurological Disorders Market report are Allogeneic Placental Stem Cell Therapy, Autologous Placental Stem Cell Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Allogeneic Placental Stem Cell Therapy

1.2.3 Autologous Placental Stem Cell Therapy

1.3 Market by Application

1.3.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals and Specialist Clinics

1.3.3 Clinical Research Institute

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Perspective (2020-2031)

2.2 Global Placental Stem Cell Therapy for Neurological Disorders Growth Trends by Region

2.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Region (2020-2025)

2.2.3 Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031)

2.3 Placental Stem Cell Therapy for Neurological Disorders Market Dynamics

2.3.1 Placental Stem Cell Therapy for Neurological Disorders Industry Trends

2.3.2 Placental Stem Cell Therapy for Neurological Disorders Market Drivers

2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Challenges

2.3.4 Placental Stem Cell Therapy for Neurological Disorders Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue

3.1.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue (2020-2025)

3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Players (2020-2025)

3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Placental Stem Cell Therapy for Neurological Disorders Revenue

3.4 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio

3.4.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024

3.5 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders Head office and Area Served

3.6 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application

3.7 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Type

4.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Type (2020-2025)

4.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031)

5 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Application

5.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Application (2020-2025)

5.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)

6.2 North America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)

6.4 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)

7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)

7.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)

8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025)

8.4 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)

9.2 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)

9.4 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)

10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)

10.4 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Mesoblast

11.1.1 Mesoblast Company Details

11.1.2 Mesoblast Business Overview

11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction

11.1.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.1.5 Mesoblast Recent Development

11.2 Pleurite Therapeutic

11.2.1 Pleurite Therapeutic Company Details

11.2.2 Pleurite Therapeutic Business Overview

11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Introduction

11.2.4 Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.2.5 Pleurite Therapeutic Recent Development

11.3 Athersys

11.3.1 Athersys Company Details

11.3.2 Athersys Business Overview

11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Introduction

11.3.4 Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.3.5 Athersys Recent Development

11.4 Cordlife India

11.4.1 Cordlife India Company Details

11.4.2 Cordlife India Business Overview

11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Introduction

11.4.4 Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.4.5 Cordlife India Recent Development

11.5 Life Cell

11.5.1 Life Cell Company Details

11.5.2 Life Cell Business Overview

11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Introduction

11.5.4 Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.5.5 Life Cell Recent Development

11.6 Cryo-Cell

11.6.1 Cryo-Cell Company Details

11.6.2 Cryo-Cell Business Overview

11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Introduction

11.6.4 Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.6.5 Cryo-Cell Recent Development

11.7 CBR Systems

11.7.1 CBR Systems Company Details

11.7.2 CBR Systems Business Overview

11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Introduction

11.7.4 CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.7.5 CBR Systems Recent Development

11.8 ReNeuron Group

11.8.1 ReNeuron Group Company Details

11.8.2 ReNeuron Group Business Overview

11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Introduction

11.8.4 ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.8.5 ReNeuron Group Recent Development

11.9 Cynata

11.9.1 Cynata Company Details

11.9.2 Cynata Business Overview

11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Introduction

11.9.4 Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.9.5 Cynata Recent Development

11.10 Celularity

11.10.1 Celularity Company Details

11.10.2 Celularity Business Overview

11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Introduction

11.10.4 Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.10.5 Celularity Recent Development

11.11 Americord Registry

11.11.1 Americord Registry Company Details

11.11.2 Americord Registry Business Overview

11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Introduction

11.11.4 Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.11.5 Americord Registry Recent Development

11.12 ReeLabs

11.12.1 ReeLabs Company Details

11.12.2 ReeLabs Business Overview

11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Introduction

11.12.4 ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.12.5 ReeLabs Recent Development

11.13 Mesoblast

11.13.1 Mesoblast Company Details

11.13.2 Mesoblast Business Overview

11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction

11.13.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

11.13.5 Mesoblast Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Allogeneic Placental Stem Cell Therapy

Table 3. Key Players of Autologous Placental Stem Cell Therapy

Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2025)

Table 8. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2026-2031)

Table 10. Placental Stem Cell Therapy for Neurological Disorders Market Trends

Table 11. Placental Stem Cell Therapy for Neurological Disorders Market Drivers

Table 12. Placental Stem Cell Therapy for Neurological Disorders Market Challenges

Table 13. Placental Stem Cell Therapy for Neurological Disorders Market Restraints

Table 14. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players (2020-2025)

Table 16. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)

Table 17. Ranking of Global Top Placental Stem Cell Therapy for Neurological Disorders Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Headquarters and Area Served

Table 20. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application

Table 21. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2020-2025)

Table 25. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2026-2031)

Table 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2020-2025)

Table 29. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2026-2031)

Table 31. North America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 46. Mesoblast Company Details

Table 47. Mesoblast Business Overview

Table 48. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product

Table 49. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 50. Mesoblast Recent Development

Table 51. Pleurite Therapeutic Company Details

Table 52. Pleurite Therapeutic Business Overview

Table 53. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product

Table 54. Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 55. Pleurite Therapeutic Recent Development

Table 56. Athersys Company Details

Table 57. Athersys Business Overview

Table 58. Athersys Placental Stem Cell Therapy for Neurological Disorders Product

Table 59. Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 60. Athersys Recent Development

Table 61. Cordlife India Company Details

Table 62. Cordlife India Business Overview

Table 63. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product

Table 64. Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 65. Cordlife India Recent Development

Table 66. Life Cell Company Details

Table 67. Life Cell Business Overview

Table 68. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product

Table 69. Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 70. Life Cell Recent Development

Table 71. Cryo-Cell Company Details

Table 72. Cryo-Cell Business Overview

Table 73. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product

Table 74. Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 75. Cryo-Cell Recent Development

Table 76. CBR Systems Company Details

Table 77. CBR Systems Business Overview

Table 78. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product

Table 79. CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 80. CBR Systems Recent Development

Table 81. ReNeuron Group Company Details

Table 82. ReNeuron Group Business Overview

Table 83. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product

Table 84. ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 85. ReNeuron Group Recent Development

Table 86. Cynata Company Details

Table 87. Cynata Business Overview

Table 88. Cynata Placental Stem Cell Therapy for Neurological Disorders Product

Table 89. Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 90. Cynata Recent Development

Table 91. Celularity Company Details

Table 92. Celularity Business Overview

Table 93. Celularity Placental Stem Cell Therapy for Neurological Disorders Product

Table 94. Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 95. Celularity Recent Development

Table 96. Americord Registry Company Details

Table 97. Americord Registry Business Overview

Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product

Table 99. Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 100. Americord Registry Recent Development

Table 101. ReeLabs Company Details

Table 102. ReeLabs Business Overview

Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product

Table 104. ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 105. ReeLabs Recent Development

Table 106. Mesoblast Company Details

Table 107. Mesoblast Business Overview

Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product

Table 109. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)

Table 110. Mesoblast Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Placental Stem Cell Therapy for Neurological Disorders Picture

Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Type: 2024 VS 2031

Figure 4. Allogeneic Placental Stem Cell Therapy Features

Figure 5. Autologous Placental Stem Cell Therapy Features

Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Application: 2024 VS 2031

Figure 8. Hospitals and Specialist Clinics Case Studies

Figure 9. Clinical Research Institute Case Studies

Figure 10. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered

Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Placental Stem Cell Therapy for Neurological Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region: 2024 VS 2031

Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players in 2024

Figure 15. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024

Figure 17. North America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)

Figure 19. United States Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)

Figure 23. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2031)

Figure 31. China Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)

Figure 39. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)

Figure 43. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 47. Pleurite Therapeutic Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 48. Athersys Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 49. Cordlife India Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 50. Life Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 51. Cryo-Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 52. CBR Systems Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 53. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 54. Cynata Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 55. Celularity Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 56. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 57. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 58. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions